Research On Inventory Management Optimization Of H Pharmaceutical Company

In recent years,my country’s pharmaceutical industry has developed rapidly as a whole and is regarded as a sunrise industry.However,under the momentum of its rapid development,on the one hand,the state has strengthened the supervision and regulation of the pharmaceutical industry,and a series of cost control and price reduction policies have led to a downward trend in drug prices,which has seriously compressed the profit margins of pharmaceutical companies;The acceleration of updates and iterations and the influx of new entrants on the generic drug competition track have intensified competition among pharmaceutical companies.From the disorderly competition around generic drugs in the past to a healthy competition dominated by innovation,pharmaceutical companies need to concentrate more Funds are invested in research and development,and the trend of survival of the fittest in the pharmaceutical industry is emerging.Therefore,under this severe background,the efficient management of pharmaceutical companies will help save operating costs and enhance competitiveness.The operation of pharmaceutical companies revolves around drugs,and as the main inventory of pharmaceutical companies,the level of management efficiency of drugs will affect the overall business results to a certain extent.Inventory management often has some problems,which restrict the long-term development of enterprises.Therefore,this paper takes H Pharmaceutical Company as the research object,sorts out the relevant literature on inventory management,and on this basis understands the process of H Company’s inventory management activities.Have a clear understanding of the production process and sales collection process,and found that there are problems such as serious inventory value loss,slow turnover,backlog of inventory,and unreasonable classification.The analysis of the specific causes found that it was mainly caused by the epidemic affecting the price fluctuation of the API market,resulting in the decline of inventory prices,the monopoly of suppliers affecting the production plan,the vague division of responsibilities of the storage and transportation department,and the lack of drug application approval progress management.Finally,combined with the detailed analysis of the case companies in this paper,targeted optimization measures are proposed from the procurement,storage,and sales links,and corresponding optimization suggestions based on the whole process are put forward to help solve the inventory management problems of H company.The research in this paper has certain guiding significance and value for H company to optimize inventory management,further enhance synergy efficiency,improve management efficiency,provide reference for peer companies with similar background and characteristics,and promote the overall development of the pharmaceutical industry.